Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Epidemics ; 44: 100710, 2023 09.
Article in English | MEDLINE | ID: mdl-37556994

ABSTRACT

The spread of SARS-CoV-2, like that of many other pathogens, is governed by heterogeneity. "Superspreading," or "over-dispersion," is an important factor in transmission, yet it is hard to quantify. Estimates from contact tracing data are prone to potential biases due to the increased likelihood of detecting large clusters of cases, and may reflect variation in contact behavior more than biological heterogeneity. In contrast, the average number of secondary infections per contact is routinely estimated from household surveys, and these studies can minimize biases by testing all members of a household. However, the models used to analyze household transmission data typically assume that infectiousness and susceptibility are the same for all individuals or vary only with predetermined traits such as age. Here we develop and apply a combined forward simulation and inference method to quantify the degree of inter-individual variation in both infectiousness and susceptibility from observations of the distribution of infections in household surveys. First, analyzing simulated data, we show our method can reliably ascertain the presence, type, and amount of these heterogeneities given data from a sufficiently large sample of households. We then analyze a collection of household studies of COVID-19 from diverse settings around the world, and find strong evidence for large heterogeneity in both the infectiousness and susceptibility of individuals. Our results also provide a framework to improve the design of studies to evaluate household interventions in the presence of realistic heterogeneity between individuals.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , SARS-CoV-2 , Contact Tracing/methods , Family Characteristics , Computer Simulation
2.
IEEE Trans Biomed Eng ; 70(3): 1053-1061, 2023 03.
Article in English | MEDLINE | ID: mdl-36129868

ABSTRACT

OBJECTIVE: The diagnosis of urinary tract infection (UTI) currently requires precise specimen collection, handling infectious human waste, controlled urine storage, and timely transportation to modern laboratory equipment for analysis. Here we investigate holographic lens free imaging (LFI) to show its promise for enabling automatic urine analysis at the patient bedside. METHODS: We introduce an LFI system capable of resolving important urine clinical biomarkers such as red blood cells, white blood cells, crystals, and casts in 2 mm thick urine phantoms. RESULTS: This approach is sensitive to the particulate concentrations relevant for detecting several clinical urine abnormalities such as hematuria and pyuria, linearly correlating to ground truth hemacytometer measurements with R 2 = 0.9941 and R 2 = 0.9973, respectively. We show that LFI can estimate E. coli concentrations of 10 3 to 10 5 cells/mL by counting individual cells, and is sensitive to concentrations of 10 5 cells/mL to 10 8 cells/mL by analyzing hologram texture. Further, LFI measurements of blood cell concentrations are relatively insensitive to changes in bacteria concentrations of over seven orders of magnitude. Lastly, LFI reveals clear differences between UTI-positive and UTI-negative urine from human patients. CONCLUSION: LFI is sensitive to clinically-relevant concentrations of bacteria, blood cells, and other sediment in large urine volumes. SIGNIFICANCE: Together, these results show promise for LFI as a tool for urine screening, potentially offering early, point-of-care detection of UTI and other pathological processes.


Subject(s)
Urinalysis , Urinary Tract Infections , Urinalysis/instrumentation , Urinalysis/methods , Urinary Tract Infections/diagnostic imaging , Point-of-Care Testing/standards , Urine/cytology , Urine/microbiology , Holography , Humans , Sensitivity and Specificity
3.
medRxiv ; 2022 Dec 06.
Article in English | MEDLINE | ID: mdl-36523404

ABSTRACT

The spread of SARS-CoV-2, like that of many other pathogens, is governed by heterogeneity. "Superspreading," or "over-dispersion," is an important factor in transmission, yet it is hard to quantify. Estimates from contact tracing data are prone to potential biases due to the increased likelihood of detecting large clusters of cases, and may reflect variation in contact behavior more than biological heterogeneity. In contrast, the average number of secondary infections per contact is routinely estimated from household surveys, and these studies can minimize biases by testing all members of a household. However, the models used to analyze household transmission data typically assume that infectiousness and susceptibility are the same for all individuals or vary only with predetermined traits such as age. Here we develop and apply a combined forward simulation and inference method to quantify the degree of inter-individual variation in both infectiousness and susceptibility from observations of the distribution of infections in household surveys. First, analyzing simulated data, we show our method can reliably ascertain the presence, type, and amount of these heterogeneities with data from a sufficiently large sample of households. We then analyze a collection of household studies of COVID-19 from diverse settings around the world, and find strong evidence for large heterogeneity in both the infectiousness and susceptibility of individuals. Our results also provide a framework to improve the design of studies to evaluate household interventions in the presence of realistic heterogeneity between individuals.

4.
Opt Express ; 30(19): 33433-33448, 2022 Sep 12.
Article in English | MEDLINE | ID: mdl-36242380

ABSTRACT

In-line lensless digital holography has great potential in multiple applications; however, reconstructing high-quality images from a single recorded hologram is challenging due to the loss of phase information. Typical reconstruction methods are based on solving a regularized inverse problem and work well under suitable image priors, but they are extremely sensitive to mismatches between the forward model and the actual imaging system. This paper aims to improve the robustness of such algorithms by introducing the adaptive sparse reconstruction method, ASR, which learns a properly constrained point spread function (PSF) directly from data, as opposed to solely relying on physics-based approximations of it. ASR jointly performs holographic reconstruction, PSF estimation, and phase retrieval in an unsupervised way by maximizing the sparsity of the reconstructed images. Like traditional methods, ASR uses the image formation model along with a sparsity prior, which, unlike recent deep learning approaches, allows for unsupervised reconstruction with as little as one sample. Experimental results in synthetic and real data show the advantages of ASR over traditional reconstruction methods, especially in cases where the theoretical PSF does not match that of the actual system.

5.
Am J Health Syst Pharm ; 77(24): 2081-2088, 2020 Dec 04.
Article in English | MEDLINE | ID: mdl-33150407

ABSTRACT

PURPOSE: Healthcare facilities are obligated to implement strategies to protect healthcare workers from exposure to hazardous drugs, including any real or potential risk from contaminated surfaces. Guidelines are broad and lack sufficient detail for healthcare facilities to establish clear effectiveness targets for their decontamination procedures. Our goal in this analysis was to measure the effectiveness of a decontamination procedure in a pharmacy buffer room contaminated with 5 antineoplastic drugs. METHODS: Six rounds of contamination, decontamination, and wipe sampling were performed in a pharmacy buffer room designated for hazardous drug (HD) compounding. Ten locations in the buffer room were contaminated with 5-fluorouracil, carboplatin, cyclophosphamide, paclitaxel, and doxorubicin. Pharmacy staff were blinded to contamination sites. After contamination, 3 pharmacy technicians following the same decontamination procedure decontaminated the buffer room. To assess the impact of decontamination, residual hazardous drug levels were assessed after contamination and after decontamination using a commercially available wipe sampling product. RESULTS: The mean (SD) residual contamination levels for the 239 wipe samples taken before and after decontamination were 63 (60) ng and 3.9 (8.2) ng, respectively, representing a 94% reduction in residual HD contamination. Residual contamination was not detectable (<5 ng) in 221 (~93%) of the samples after decontamination. CONCLUSION: The employed decontamination procedures effectively reduced residual HD surface contamination.


Subject(s)
Antineoplastic Agents/analysis , Decontamination/methods , Equipment Contamination/prevention & control , Pharmacy Service, Hospital/standards , Antineoplastic Agents/chemistry , Drug Compounding , Environmental Monitoring/methods , Humans , Pharmacy Technicians/organization & administration
SELECTION OF CITATIONS
SEARCH DETAIL
...